Market Update – Elixinol Japan Operations
Elixinol Global Limited (Elixinol Global or the Company) (ASX:EXL; OTCQX:ELLXF), today announces that the Company has established that non-compliant hemp-derived CBD products were being sold by Elixinol Japan.
The breach was discovered internally following the recent review of each global business unit’s operations. The Company takes its compliance with all legislation and regulations seriously and is conducting an investigation into the circumstances of the non-compliance in relation to the hemp- derived CBD business unit within Elixinol Japan.
For further information please download the attached PDF:
Download this document
